Significant spread of all coronavirus variants tracked in Houston area

Study underscores the need for greatly increased genome surveillance to rapidly identify and track the emergence and introduction of SARS-CoV-2 variants in the United States, investigators report in The American Journal of Pathology
15-Apr-2021 12:55 PM EDT, by Elsevier

Newswise — Philadelphia, April 14, 2021 - In late 2020, several concerning SARS-CoV-2 variants emerged globally. They are believed to be more easily transmissible, and there is concern that some may reduce the effectiveness of antibody treatments and vaccines. An extensive genome sequencing program run by the Houston Methodist health system has identified all six of the currently identified SARS-CoV-2 variants in their patients. A new study appearing in The American Journal of Pathology, published by Elsevier, finds that the variants are widely spread across the Houston metropolitan area.

"Before the SARS-CoV-2 virus arrived in Houston, we planned an integrated strategy to confront and mitigate this microbial threat to our patients," explains lead investigator James M. Musser, MD, PhD, chair of the Department of Pathology and Genomic Medicine at Houston Methodist and Fondren Presidential Distinguished Chair with Houston Methodist Research Institute, Houston, TX, USA. "We instituted a plan to sequence the genome of every positive specimen from patients within the Houston Methodist system with the goal of understanding pathogen spread in our community and identifying biologically-important mutant viruses."

Dr. Musser notes that Greater Houston is the first metropolitan multiplex in the United States that has documented all of these important and concerning variants circulating among its residents. The Houston Methodist health system has one of the largest SARS-CoV-2 genome sequencing operations in the US and has so far sequenced 20,453 genomes from clinical specimens collected from patients from March 2020 to February 2021. Patient home address zip codes were used to see how the variants spread across Greater Houston's large, multiethnic, and geographically and socioeconomically diverse population.

The UK variant known as B.1.1.7 was first identified in a patient in Houston in January 2021 and has been found in 23 patients through February 2021. The California variants, B.1.429 and B.1.427 were first found in Houston in late December 2020. Variant B.1.429 has been identified in 143 patients in Houston and variant B.1.427 in 19 patients. The South African variant B.1.351 was first detected in Houston in two patients in December 2020 and January 2021. The Brazil variant P.1 has been identified in four patients since mid-January 2021 and P.2 in 39 patients since late December 2020.

With the exception of B.1.351, the investigators found geographically widespread dissemination of the variants, indicating successful patient-to-patient transmission among the communities. None of the patients were from a common household or reported recent international travel, suggesting that every infection was independently acquired locally or during domestic travel.

Initially Dr. Musser and co-investigators had observed that although the P.2 infection was numerically a minor cause of all Houston-area infections, it was the most common variant of concern in their population because its mutation has the potential to neutralize treatments and vaccines. Continued monitoring of the Houston area shows that the UK B.1.1.7 variant is now the most prevalent variant. According to Dr. Musser, "Emergence of new variants underscores the need for ongoing extensive genomic sequencing efforts for early identification and public health warning."

By linking the SARS-CoV-2 whole genome sequencing data to patient metadata in the electronic medical record, Houston Methodist is able to use analytic tools such as high-performance compute clusters and machine learning to investigate the genomic diversity and characteristics such as strain virulence or patient outcomes. "Our goal is to sequence the SARS-CoV-2 genome of every infected patient in our healthcare system in near-real time and expand outward to other patients in our community," Dr. Musser states. "Our results underscore the need to greatly increase genome surveillance to rapidly identify and track the introduction of new SARS-CoV-2 variants in the U.S. and in local areas."

Dr. Musser and his co-investigators have noted that in the last three weeks, Houston Methodist cases of the UK variant have increased to almost 1,600 from 648. They advise that because vaccination is the best way to decrease the number of circulating COVID-19 variants, a much larger percentage of the population needs to get vaccinated. In the meantime, the team is keeping a very close eye on the variants and the type of disease they cause.

###

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 5639
access_time Embargo lifts in 2 days
Embargo will expire: 20-May-2021 10:00 AM EDT Released to reporters: 14-May-2021 2:40 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 20-May-2021 10:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 14-May-2021 11:25 AM EDT
Access to overdose-reversing drugs declined during pandemic, researchers find
Beth Israel Lahey Health

In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions.

Released: 14-May-2021 11:00 AM EDT
No Excuses: Stop Procrastinating on These Key Health Checks
Michigan Medicine - University of Michigan

A quick guide to the most-valuable preventive care that adults need to get scheduled, to catch up on what they may have missed during the height of the pandemic, and to address issues that the pandemic might have worsened.

Released: 13-May-2021 7:05 PM EDT
FLCCC Statement on the Irregular Actions of Public Health Agencies & the Disinformation Campaign Against Ivermectin
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

FLCCC Alliance calls for whistleblower to step forward from within WHO, the FDA, the NIH, Merck, or Unitaid to counter this misrepresentation

Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:15 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.


Showing results

110 of 5639

close
2.79611